{
    "info": {
        "nct_id": "NCT06101134",
        "official_title": "A Phase 2 Open-label, Two-cohort Study to Evaluate Patient Preference for Nivolumab + Relatlimab Fixed-dose Combination Subcutaneous Versus Nivolumab + Relatlimab Fixed-dose Combination Intravenous and Nivolumab Subcutaneous Versus Nivolumab Intravenous in Participants With Melanoma",
        "inclusion_criteria": "* Must have either metastatic melanoma and have not had previous treatment for their cancer, or resected melanoma and have had the cancer removed fully with surgery no later than 12 weeks before the start of treatment and confirmed free of disease\n* Must have a low level of disability and cancer that is considered advanced for metastatic melanoma and at risk for becoming advanced (intermediate) or advanced for resected melanoma\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Must not have any brain cancer/disease treated with radiation, any cancer in the eyes or mucous membranes (cells that cover inside surface of parts of the body and keep it moist), any autoimmune disease, or any condition that is being treated with steroids for inflammation (corticosteroids) or medication to decrease the body's immune system response (immunosuppressive drugs)\n\nOther protocol-defined inclusion/exclusion criteria apply.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Must have either metastatic melanoma and have not had previous treatment for their cancer, or resected melanoma and have had the cancer removed fully with surgery no later than 12 weeks before the start of treatment and confirmed free of disease",
            "criterions": [
                {
                    "exact_snippets": "metastatic melanoma and have not had previous treatment for their cancer",
                    "criterion": "metastatic melanoma",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "prior treatment",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "resected melanoma and have had the cancer removed fully with surgery no later than 12 weeks before the start of treatment and confirmed free of disease",
                    "criterion": "resected melanoma",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "cancer removed fully with surgery",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "time since surgery",
                            "expected_value": {
                                "operator": "<=",
                                "value": 12,
                                "unit": "weeks"
                            }
                        },
                        {
                            "requirement_type": "free of disease",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Must have a low level of disability and cancer that is considered advanced for metastatic melanoma and at risk for becoming advanced (intermediate) or advanced for resected melanoma",
            "criterions": [
                {
                    "exact_snippets": "Must have a low level of disability",
                    "criterion": "disability level",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "low"
                        }
                    ]
                },
                {
                    "exact_snippets": "cancer that is considered advanced for metastatic melanoma",
                    "criterion": "cancer stage (metastatic melanoma)",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "advanced"
                        }
                    ]
                },
                {
                    "exact_snippets": "at risk for becoming advanced (intermediate)",
                    "criterion": "cancer progression risk (metastatic melanoma)",
                    "requirements": [
                        {
                            "requirement_type": "risk of progression",
                            "expected_value": "intermediate or advanced"
                        }
                    ]
                },
                {
                    "exact_snippets": "advanced for resected melanoma",
                    "criterion": "cancer stage (resected melanoma)",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "advanced"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "Other protocol-defined inclusion/exclusion criteria apply.",
            "criterions": [
                {
                    "exact_snippets": "Other protocol-defined inclusion/exclusion criteria apply.",
                    "criterion": "other protocol-defined inclusion/exclusion criteria",
                    "requirements": [
                        {
                            "requirement_type": "applicability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Must not have any brain cancer/disease treated with radiation, any cancer in the eyes or mucous membranes (cells that cover inside surface of parts of the body and keep it moist), any autoimmune disease, or any condition that is being treated with steroids for inflammation (corticosteroids) or medication to decrease the body's immune system response (immunosuppressive drugs)",
            "criterions": [
                {
                    "exact_snippets": "Must not have any brain cancer/disease treated with radiation",
                    "criterion": "brain cancer or brain disease treated with radiation",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "any cancer in the eyes or mucous membranes",
                    "criterion": "cancer in the eyes or mucous membranes",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "any autoimmune disease",
                    "criterion": "autoimmune disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "any condition that is being treated with steroids for inflammation (corticosteroids)",
                    "criterion": "condition treated with steroids for inflammation",
                    "requirements": [
                        {
                            "requirement_type": "treatment with steroids for inflammation",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "any condition that is being treated with ... medication to decrease the body's immune system response (immunosuppressive drugs)",
                    "criterion": "condition treated with immunosuppressive drugs",
                    "requirements": [
                        {
                            "requirement_type": "treatment with immunosuppressive drugs",
                            "expected_value": false
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}